Premium
Renal insufficiency mimicking glutaric acidemia type 1 on newborn screening
Author(s) -
Matsumoto Masaaki,
Awano Hiroyuki,
Bo Ryosuke,
Nagai Masashi,
Tomioka Kazumi,
Nishiyama Masahiro,
Ninchouji Takeshi,
Nagase Hiroaki,
Yagi Mariko,
Morioka Ichiro,
Hasegawa Yuki,
Takeshima Yasuhiro,
Iijima Kazumoto
Publication year - 2018
Publication title -
pediatrics international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.49
H-Index - 63
eISSN - 1442-200X
pISSN - 1328-8067
DOI - 10.1111/ped.13438
Subject(s) - medicine , newborn screening , differential diagnosis , carnitine , pathological , urinary system , glutaric acid , pediatrics , gastroenterology , pathology , biochemistry , chemistry
Abstract Background Glutaryl carnitine (C5 DC ) in dried blood spots is used as a biomarker for glutaric aciduria type 1 ( GA ‐1) screening. C5 DC , however, is the only screening marker for this condition, and various pathological conditions may interfere with C5 DC metabolism. Recently, C5 DC elevation has been reported in cases of renal insufficiency. Method Five patients who were positive for GA ‐1 on newborn screening with tandem mass spectrometry between September 2012 and March 2015 at Kobe University Hospital were enrolled in this study. Results GA ‐1 was not confirmed on urinary organic acids analysis in any of the patients. C5 DC decreased immediately in four patients, but one patient, who had high C5 DC for at least 4 months, was diagnosed with bilateral renal hypoplasia. Conclusion In the case of persistently elevated C5 DC , renal insufficiency should be considered as a differential diagnosis.